Search

Search bills, members, committees and pages...

Sign In

NOVARTIS

PreviousNext

116 federal lobbying filings, 2023 to 2026.

NOVARTIS is a client on 116 federal lobbying filings, 2023 to 2026, reporting $5.1M across them. Vaccine and diagnostic manufacturing Based in District of Columbia.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Firms

10 it has hired, by filings.

RegistrantFilingsReported
NOVARTIS17—
BGR GOVERNMENT AFFAIRS16$860K
BROWNSTEIN HYATT FARBER SCHRECK, LLP16$1.1M
TIBER CREEK HEALTH STRATEGIES, INC.16$960K
TARPLIN, DOWNS & YOUNG, LLC15$840K
MONUMENT ADVOCACY14$480K
CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS7$270K
RESOLUTION PUBLIC AFFAIRS, LLC7$270K
DLA PIPER LLP (US)6$280K
EAST END GROUP, LLC2$90K

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
202616$880K$5.3M
202535$1.5M$10.3M
202431$1.5M$6M
202334$1.3M$6.6M

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues103
MMMMedicare/Medicaid67
TRDTrade (domestic/foreign)42
TAXTaxation/Internal Revenue Code36
BUDBudget/Appropriations32
CPTCopyright/Patent/Trademark22
LBRLabor Issues/Antitrust/Workplace17
SCIScience/Technology4
MANManufacturing2
MEDMedical/Disease Research/Clinical Labs2
PHAPharmacy2
VETVeterans2

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1672Maintaining Investments in New Innovation Act31
H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…13
S. 832EPIC Act of 202513
H.R. 1262Mikaela Naylon Give Kids a Chance Act8
H.R. 2214DRUG Act8
H.R. 2425Kairo Act of 20258
H.R. 946ORPHAN Cures Act8
H.R. 950Saving Seniors Money on Prescriptions Act8
S. 1041Affordable Prescriptions for Patients Act8
S. 1095Stop STALLING Act8
S. 1096Preserve Access to Affordable Generics and Biosimilars Act8
S. 1097Interagency Patent Coordination and Improvement Act of 20258
S. 864HELP Copays Act8
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.7
H.R. 3037Access to Breast Cancer Diagnosis Act of 20257
H.R. 3152Patent Eligibility Restoration Act of 20257
H.R. 3160PREVAIL Act7
H.R. 3269ETHIC Act7
S. 1500Access to Breast Cancer Diagnosis Act of 20257
S. 43Skinny Labels, Big Savings Act7
H.R. 5256340B ACCESS Act5
S. 2276ETHIC Act5
S. 932Give Kids a Chance Act of 20255
H.R. 5371Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and E…3
S. 1682Alex Gate Safety Act of 20253

Lobbyists

Named on the filings.

LobbyistClientsFilings
COURTNEY LEE-ASHLEY117
COURTNEY PIRON117
JOSEPH MCGOWAN117
TAYLOR BOOTH117
ADAM STEINMETZ116
BRENT DEL MONTE116
DANIEL FARMER116
EMILY FELDER116
JOEL BAILEY116
JOHN STONE116
LEO FARBER116
REMY MASON116
ROBB WALTON116
ZACHARY PFISTER116
CHARLOTTE IVANCIC115
DEEMA TARAZI115
ELIZABETH MURRAY115
EMILY MURRY115
JENNIFER YOUNG115
MARGARET JOSEPH115
PAMELA SMITH115
PETER FISE115
RAISSA DOWNS115
KIMBERLY ELLIS114
RICH THOMAS114

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
NOVARTISTARPLIN, DOWNS & YOUNG, LLC2026 second_quarter$60KJul 21, 2026
NOVARTISDLA PIPER LLP (US)2026 second_quarter$60KJul 20, 2026
NOVARTISBROWNSTEIN HYATT FARBER SCHRECK, LLP2026 second_quarter$90KJul 20, 2026
NOVARTISNOVARTIS2026 second_quarter$1.4MJul 20, 2026
NOVARTISBGR GOVERNMENT AFFAIRS2026 second_quarter$60KJul 20, 2026
NOVARTISMONUMENT ADVOCACY2026 second_quarter$60KJul 20, 2026
NOVARTISTIBER CREEK HEALTH STRATEGIES, INC.2026 second_quarter$60KJul 18, 2026
NOVARTISCORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS2026 second_quarter$50KJul 16, 2026
NOVARTISMONUMENT ADVOCACY2026 first_quarter$60KApr 20, 2026
NOVARTISBROWNSTEIN HYATT FARBER SCHRECK, LLP2026 first_quarter$90KApr 20, 2026
NOVARTISTARPLIN, DOWNS & YOUNG, LLC2026 first_quarter$60KApr 20, 2026
NOVARTISTIBER CREEK HEALTH STRATEGIES, INC.2026 first_quarter$60KApr 20, 2026
NOVARTISDLA PIPER LLP (US)2026 first_quarter$60KApr 20, 2026
NOVARTISBGR GOVERNMENT AFFAIRS2026 first_quarter$60KApr 20, 2026
NOVARTISNOVARTIS2026 first_quarter$3.9MApr 20, 2026
NOVARTISCORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS2026 first_quarter$50KApr 20, 2026
NOVARTISNOVARTIS2025 third_quarter$1.7MMar 9, 2026
NOVARTISNOVARTIS2025 second_quarter$920KMar 9, 2026
NOVARTISTARPLIN, DOWNS & YOUNG, LLC2025 fourth_quarter$60KJan 20, 2026
NOVARTISBROWNSTEIN HYATT FARBER SCHRECK, LLP2025 fourth_quarter$70KJan 20, 2026
NOVARTISNOVARTIS2025 fourth_quarter$1MJan 20, 2026
NOVARTISDLA PIPER LLP (US)2025 fourth_quarter$60KJan 20, 2026
NOVARTISTIBER CREEK HEALTH STRATEGIES, INC.2025 fourth_quarter$60KJan 20, 2026
NOVARTISMONUMENT ADVOCACY2025 fourth_quarter$30KJan 20, 2026
NOVARTISBGR GOVERNMENT AFFAIRS2025 fourth_quarter$60KJan 20, 2026